24 May 2013
Keywords: use, cannabis, ms, clear, say, trial, data
Article | 17 November 2003
A trial evaluating the use of cannabinoids for the treatment of symptomsof multiple sclerosis has provided mixed results. The findings ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
17 November 2003
23 May 2013
© 2013 thepharmaletter.com